Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apo A-I binding to platelets detected by flow cytometry.

D Ozsavci1, T Yardimci, G Y Demirel

  • 1Department of Biochemistry, Marmara University Faculty of Pharmacy, Tibbiye Caddesi, No. 49, Haydarpasa, Kadikoy 81010, Istanbul, Turkey. ariza@anet.net.tr

Thrombosis Research
|July 18, 2001
PubMed
Summary

Apolipoprotein A-I binds to platelets, suggesting a key role in high-density lipoprotein (HDL) interactions. This binding is reduced in hypercholesterolemic individuals upon platelet activation, highlighting potential implications for atherosclerosis and thrombosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Native High-Density Lipoprotein and Melatonin Improve Platelet Response Induced by Glycated Lipoproteins.

Folia biologica·2019
Same author

The effect of exogenous oxytocin on streptozotocin (STZ)-induced diabetic adult rat testes.

Peptides·2014
Same author

Plasma levels of growth arrest specific protein 6 are increased in idiopathic recurrent pregnancy loss.

European review for medical and pharmacological sciences·2014
Same author

Influence of platelet γ-glutamyltransferase on oxidative stress and apoptosis in the presence of holo-transferrin.

Folia biologica·2012
Same author

In vitro effects of nitric oxide donors on apoptosis and oxidative/nitrative protein modifications in ADP-activated platelets.

Human & experimental toxicology·2012
Same author

Oxidized-LDL and Fe3+/ascorbic acid-induced oxidative modifications and phosphatidylserine exposure in human platelets are reduced by melatonin.

Folia biologica·2009

Area of Science:

  • Cardiovascular Biology
  • Lipid Metabolism
  • Platelet Physiology

Background:

  • Lipoprotein-platelet interactions are crucial in atherosclerosis and thrombosis.
  • Understanding high-density lipoprotein (HDL) receptors and their binding specificity is limited.
  • Apolipoprotein (apo) A-I is hypothesized to be central to HDL receptor specificity.

Purpose of the Study:

  • To investigate the binding of apo A-I to platelets.
  • To explore potential differences in apo A-I binding between healthy and hypercholesterolemic subjects.
  • To determine the effect of platelet activation on apo A-I binding.

Main Methods:

  • Flow cytometry was used to analyze apo A-I binding to platelets.
  • Blood samples from healthy and hypercholesterolemic subjects were analyzed.

Related Experiment Videos

  • Platelets were activated using ADP or thrombin receptor agonist peptide (TRAP) prior to analysis.

    • Main Results:

    • Apo A-I was demonstrated to bind to platelets.
    • In hypercholesterolemic subjects, TRAP activation significantly decreased apo A-I binding (P<.05).
    • Platelet activation with ADP or TRAP did not significantly alter apo A-I binding in healthy controls (P>.05).

    Conclusions:

    • Apo A-I binding to platelets supports its role in HDL-platelet interactions.
    • Altered apo A-I binding in hypercholesterolemia may contribute to cardiovascular disease pathogenesis.
    • Further research into apo A-I's function in platelet biology is warranted.